某院血脂异常患者使用调节血脂药物的抽样调查分析  

Analysis on use of lipid regulating drug in dyslipidemia patients in a hospital

作　　者：田晓丽[1] 

机构地区：[1]沈阳市儿童医院医务科,辽宁110032

出　　处：《中国临床新医学》2012年第12期1163-1165,共3页CHINESE JOURNAL OF NEW CLINICAL MEDICINE

摘　　要：目的了解某院血脂异常患者用药的现状和趋势及药物应用的特点,为临床医师提供药物应用数据,促进合理用药。方法选取2009-10～2010-03某院心血管内科和内分泌科血脂异常住院患者161例,分析其用药合理性,并根据评价结果提出改进药物使用措施。结果调节血脂药以阿托伐他汀、辛伐他汀、氟伐他汀、非诺贝特胶囊为主,其中阿托伐他汀是调节血脂药的首选,用药基本合理。结论该院血脂异常患者的用药基本合理。Objective To understand the present situation and tendency and characteristics of using lipid regulating drug in dyslipidemia patients and provide drug use data for clinicians, promote the rational drug use. Meth- ods One hundred and sixty-one inpatients with dyslipidemia treated in the cardiovascular department and endocrine department in a hospital form October 2009 to March 2010 were studied and drug use rationality was analyzed, and according to the evaluation results put forward the improving drug use measure. Results The main lipid regulating drugs used in a hospital were atorvastatin, simvastatin, fluastatin, fenofibrate enhances capsule. Atorvastatin was first choice in lipid regulating drugs used in a hospital. The drug use is basic reasonable. Conclusion The drug use of dyslipidemia patients in a hospital is basic reasonable.

关 键 词：血脂异常 调节血脂药物 分析 

分 类 号：R972.6[医药卫生—药品]